CD34 and neoplasm: In the tumor compartment, patients with PR had higher expression of ER-alpha, PD-L1, Pan-AKT, CD68, Ki-67, and Fibronectin, but lower expression of CD44, CD127, CD34, and VISTA (Figure 4A).